A double-edged sword: Erythropoietin eyed in retinopathy of prematurity

Journal of AAPOS

Volumn 12, Issue 3, 2008, Pages 221-222

  Chen, Jing ^a   Smith, Lois E H ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; PLACEBO; RECOMBINANT ERYTHROPOIETIN; VASCULOTROPIN;

ANEMIA; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; BLINDNESS; DISEASE COURSE; EDITORIAL; HIGH RISK PATIENT; HUMAN; HYPEROXIA; LASER COAGULATION; MAJOR CLINICAL STUDY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NEWBORN; NEWBORN MORBIDITY; NONHUMAN; OXYGEN THERAPY; PREMATURITY; PRIORITY JOURNAL; REPEATED DRUG DOSE; RETINA BLOOD VESSEL; RETROLENTAL FIBROPLASIA; RISK FACTOR; VERY LOW BIRTH WEIGHT;

ANEMIA, NEONATAL; ANIMALS; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN, RECOMBINANT; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; PROGNOSIS; RETINOPATHY OF PREMATURITY; RISK FACTORS;

EID: 45549093422     PISSN: 10918531     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaapos.2008.02.001     Document Type: Editorial

References (14)

1. Suk K.K., Dunbar J.A., Liu A., Daher N.S., Leng C.K., Leng J.K., et al. Human recombinant erythropoietin and the incidence of retinopathy of prematurity: A multiple regression model. J AAPOS 12 (2008) 233-238
2. Valentine P.H., Jackson J.C., Kalina R.E., and Woodrum D.E. Increased survival of low birth weight infants: Impact on the incidence of retinopathy of prematurity. Pediatrics 84 (1989) 442-445
3. Chen J., and Smith L.E. Retinopathy of prematurity. Angiogenesis 10 (2007) 133-140
4. Halperin D.S., Wacker P., Lacourt G., Felix M., Babel J.F., Aapro M., and Wyss M. Effects of recombinant human erythropoietin in infants with the anemia of prematurity: A pilot study. J Pediatr 116 (1990) 779-786
5. Shannon K.M., Mentzer W.C., Abels R.I., Freeman P., Newton N., Thompson D., et al. Recombinant human erythropoietin in the anemia of prematurity: Results of a placebo-controlled pilot study. J Pediatr 118 (1991) 949-955
6. Gumy-Pause F., Ozsahin H., Mermillod B., Cingria L., Berner M., and Wacker P. Stepping up versus standard doses of erythropoietin in preterm infants: A randomized controlled trial. Pediatr Hematol Oncol 22 (2005) 667-678
7. Donato H., Vain N., Rendo P., Vivas N., Prudent L., Larguia M., et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: Results of a randomized, placebo-controlled, multicenter trial. Pediatrics 105 (2000) 1066-1072
8. Maier R.F., Obladen M., Muller-Hansen I., Kattner E., Merz U., Arlettaz R., et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. J Pediatr 141 (2002) 8-15
9. Brown M.S., Baron A.E., France E.K., and Hamman R.F. Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity. J AAPOS 10 (2006) 143-149
10. Brines M., and Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 6 (2005) 484-494
11. Li F., Chong Z.Z., and Maiese K. Erythropoietin on a tightrope: Balancing neuronal and vascular protection between intrinsic and extrinsic pathways. Neurosignals 13 (2004) 265-289
12. Jaquet K., Krause K., Tawakol-Khodai M., Geidel S., and Kuck K.H. Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc Res 64 (2002) 326-333
13. Watanabe D., Suzuma K., Matsui S., Kurimoto M., Kiryu J., Kita M., et al. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med 353: (2005) 782-792
14. Chen J., Connor K.M., Aderman C.M., and Smith L.E. Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest 118 (2008) 526-533